e2e Pharma Expanding Manufacturing Facility, Offering End-To-End Co-Pack Services For CBD And Non-CBD Brands

e2e Pharma, a private label end-to-end manufacturer for CBD and non-CBD branded topicals and ingestibles that are sold direct to consumers online and through nationwide retail chains, is expanding the company’s fully operational, 30,000-square-foot manufacturing facility with four clean rooms and warehousing.

e2e’s GMP-certified manufacturing facility will help create 12-15 different white and private label form factors for brands, including topicals such as lotions, creams, balms, non-aerosol sprays and roll-ons, and ingestibles such as gummies, softgels and tinctures. The facility is able to accommodate on average about 100,000 units/week per one shift.

“We understand the game that our clients …

Full story available on Benzinga.com

e2e Pharma Expanding Manufacturing Facility, Offering End-To-End Co-Pack Services For CBD And Non-CBD Brands on Benzinga